Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.

Tameda M, Shiraki K, Sugimoto K, Ogura S, Inagaki Y, Yamamoto N, Ikejiri M, Takei Y, Ito M, Nobori T.

Cancer Sci. 2013 Jun;104(6):725-31. doi: 10.1111/cas.12149. Epub 2013 Apr 21.

2.

Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma.

Takeji S, Hirooka M, Koizumi Y, Tokumoto Y, Abe M, Ikeda Y, Nadano S, Hiasa Y, Onji M.

J Gastroenterol Hepatol. 2013 Apr;28(4):671-7. doi: 10.1111/jgh.12076.

PMID:
23215762
3.

Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma.

Tanaka T, Taniguchi T, Sannomiya K, Takenaka H, Tomonari T, Okamoto K, Kitamura S, Okahisa T, Tamaki K, Mikasa H, Suzuki S, Takayama T.

J Gastroenterol Hepatol. 2013 Aug;28(8):1348-55. doi: 10.1111/jgh.12166.

PMID:
23432345
4.

Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report.

Toyoda H, Kumada T, Osaki Y, Tada T, Kaneoka Y, Maeda A.

Cancer Sci. 2012 May;103(5):921-5. doi: 10.1111/j.1349-7006.2012.02232.x. Epub 2012 Mar 8.

5.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
6.
7.

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.

Am J Gastroenterol. 2006 Sep;101(9):2038-43. Epub 2006 Jul 18.

PMID:
16848811
8.
9.

Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.

Morimoto M, Numata K, Nozaki A, Kondo M, Moriya S, Taguri M, Morita S, Konno M, Sugo A, Miyajima E, Maeda S, Tanaka K.

Int J Clin Oncol. 2012 Aug;17(4):373-9. doi: 10.1007/s10147-011-0306-3. Epub 2011 Aug 17.

PMID:
21847534
11.

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.

Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.

Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.

PMID:
19669841
12.

Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.

Song P, Feng X, Inagaki Y, Song T, Zhang K, Wang Z, Zheng S, Ma K, Li Q, Kong D, Wu Q, Zhang T, Zhao X, Hasegawa K, Sugawara Y, Kokudo N, Tang W; Japan-China Joint Team for Medical Research and Cooperation on HCC.

Biosci Trends. 2014 Oct;8(5):266-73.

13.

Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.

Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.

Cancer. 1999 Feb 15;85(4):812-8.

PMID:
10091758
14.
15.

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.

Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA.

Cancer Biomark. 2007;3(2):79-87.

PMID:
17522429
17.

A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.

Ertle JM, Heider D, Wichert M, Keller B, Kueper R, Hilgard P, Gerken G, Schlaak JF.

Digestion. 2013;87(2):121-31. doi: 10.1159/000346080. Epub 2013 Feb 8.

PMID:
23406785
18.

NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival: a preliminary evaluation of an improved assay for PIVKA-II.

Nanashima A, Abo T, Taura N, Shibata H, Ichikawa T, Takagi K, Arai J, Oyama S, Nagayasu T.

Anticancer Res. 2013 Jun;33(6):2689-97.

PMID:
23749928
19.

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS.

Hepatology. 2003 May;37(5):1114-21.

PMID:
12717392

Supplemental Content

Support Center